C10 carbonate taxane compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S337000, C514S444000, C514S471000, C514S473000, C549S060000, C549S471000, C549S510000, C549S511000, C546S281700

Reexamination Certificate

active

07056946

ABSTRACT:
Taxanes having a carbonate substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substituents.

REFERENCES:
patent: 5175315 (1992-12-01), Holton
patent: 5227400 (1993-07-01), Holton et al.
patent: 5243045 (1993-09-01), Holton et al.
patent: 5254580 (1993-10-01), Chen et al.
patent: 5283253 (1994-02-01), Holton et al.
patent: 5350866 (1994-09-01), Holton et al.
patent: 5407674 (1995-04-01), Gabetta et al.
patent: 5430160 (1995-07-01), Holton
patent: 5475011 (1995-12-01), Ojima et al.
patent: 5556878 (1996-09-01), Kelly et al.
patent: 5567614 (1996-10-01), Patel et al.
patent: 5614645 (1997-03-01), Kingston et al.
patent: 5698712 (1997-12-01), Bombardelli et al.
patent: 5714513 (1998-02-01), Holton et al.
patent: 5721268 (1998-02-01), Holton et al.
patent: 5728849 (1998-03-01), Bouchard et al.
patent: 5780653 (1998-07-01), Tao et al.
patent: 5811452 (1998-09-01), Ojima et al.
patent: 5879929 (1999-03-01), Patel
patent: 5906990 (1999-05-01), Bouchard et al.
patent: 5912264 (1999-06-01), Wittman et al.
patent: 5939561 (1999-08-01), Bourzat et al.
patent: 5959125 (1999-09-01), Bouchard et al.
patent: 5965739 (1999-10-01), Kelly et al.
patent: 6100411 (2000-08-01), Ojima
patent: 6160135 (2000-12-01), Bouchard et al.
patent: 6214863 (2001-04-01), Bissery
patent: 0 558 959 (1993-09-01), None
patent: 0 590 267 (1994-04-01), None
patent: 0 590 267 (1994-04-01), None
patent: 0 600 517 (1994-06-01), None
patent: 0 604 910 (1994-07-01), None
patent: 0 629 701 (1994-12-01), None
patent: 0 639 577 (1995-02-01), None
patent: 0 712 854 (1996-05-01), None
patent: 9902425 (2001-04-01), None
patent: 9904046 (2001-04-01), None
patent: 10-045583 (1998-02-01), None
patent: 951134214 (1997-03-01), None
patent: WO 93/23389 (1993-11-01), None
patent: WO 94/13655 (1994-06-01), None
patent: WO 94/20484 (1994-09-01), None
patent: WO 96/13495 (1996-05-01), None
patent: WO 96/38138 (1996-12-01), None
patent: WO 97/09979 (1997-03-01), None
patent: WO 97/32578 (1997-09-01), None
patent: WO 97/42181 (1997-11-01), None
patent: WO 98/02426 (1998-01-01), None
patent: WO 99/09021 (1999-02-01), None
patent: WO 00/53592 (2000-09-01), None
patent: WO 01/57013 (2001-08-01), None
patent: WO 01/57031 (2001-08-01), None
European Search Report for related EP Application No. 01118727 dated Oct. 30, 2001.
Georgia Search Report from AP 2001 004501 dtd Feb. 6, 2003.
Gueritte-Voegelein et al., “Relationships between the Structure of Taxol Analogues and Their Antiomitotic Activity” Journal of Medicinal Ch-emistry, vol. 34, No. 3 (1991) pp. 992-998.
Gueritte Voegelein et al. “Chemical Studies of 10-Deacetyl Baccatin III. Hemisynthesis of Taxol Derivatives” Tetrahedron Letters. vol. 42, No. 16 (1986) pp. 4451-4460.
Kant et al. “A Chemoselective Approach to Functionalize the C-10 Position of 10-Deacetylbaccatin III. Synthesis and Biological Properties of Novel C-10 Taxol Analogues” Tetrahedron Letters, vol. 35, No. 30 (1994) pp. 5543-5546.
Ojima et al. “Enantiopure Fluorine-Containing Taxoids: Potent Anticancer Agents and Versatile Probes for Biomedical Problems” Journal of Fluorine Chemistry, vol. 97 (1999) pp. 3-10.
Ojima et al. “Synthesis and Structure-Activity Relationships of the Second-Generation Antitumor Taxoids: Exceptional Activity Against Drug-Resistant Cancer Cells” Journal of Medicinal Chemistry; vol. 39 (1996) pp. 3889-3896.
Ojima et al. “Synthesis and Biological Activity of Novel 3′-Trifluoromethyl Taxoids” Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 2 (1997) pp. 133-138.
Ojima et al. “Synthesis of Novel 3′-Trifluoromethyl Taxoids Through Effective Kinetic Resolution of Racemic 4-CF3-β-Lactams With Baccatins” Chirality, vol. 9 (1997) pp. 487-494.
Straubinger et al, “Pharmacology and Antitumor Effect of Novel Placlitaxel Formulations” Chapter 8, Edited by G. Georg et al., Taxane Anticancer Agents, Basic Science and Current Status, ACS Symposium Series 583, 207th the National Meeting of the American Chemical Society, San Diego, CA (1994) pp. 111-123.
International Search Report for analogous PCT Application No. PCT/US01/03588 dated Jun. 12, 2001.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

C10 carbonate taxane compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with C10 carbonate taxane compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C10 carbonate taxane compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3659009

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.